MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Clinical trial NCT02225327 · COMPLETED

Trial details

NCT number: NCT02225327
Sponsor: Korea University Guro Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human Pneumococcal Infections

Start date: 2013-10-01
Primary completion: 2013-12-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.